Multiple system atrophy (MSA)
Would you like to receive a message when there is new research about Multiple System Atrophy (MSA)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Multiple System Atrophy (MSA). View what Premium costs.
Publications and studies (1558)
- Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement. (2024/03/01) ♡
- Correlations between serotonin impairments and clinical indices in multiple system atrophy. (2024/03/01) ♡
- Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns. (2024/03/01) ♡
- Clinical Characteristics and Outcomes in Young-Onset Multiple System Atrophy. (2024/03/01) ♡
- Low Dose Amantadine and Escitalopram in Progressive Supranuclear Palsy and Multiple System Atrophy. (2024/02/07) ♡
- Frequency of Comorbid Pathologies and Their Clinical Impact in Multiple System Atrophy. (2024/02/01) ♡
- Clinical and genetic analysis of infants with pontocerebellar hypoplasia type 6 caused by RARS2 variations. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Asymptomatic orthostatic hypotension in synucleinopathies: to treat or not to treat? (2024/02/01) ♡
- Roles of the cerebellum and basal ganglia in temporal integration: Insights from a synchronized tapping task. (2024/02/01) ♡
- Peripheral Inflammatory and Immune Landscape in Multiple System Atrophy: A Cross-Sectional Study. (2024/02/01) ♡
- Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies. (2024/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Heart rate variability during sleep in synucleinopathies: a review. (2024/01/04) ♡
- Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis. (2024/01/01) ♡
- Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study. (2024/01/01) ♡
- Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis. (2024/01/01) ♡
- Ultrastructures of α-Synuclein Filaments in Synucleinopathy Brains and Experimental Models. (2024/01/01) ♡
- Cerebellar, Not Nigrostriatal Degeneration Impairs Dexterity in Multiple System Atrophy. (2024/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sobetirome rescues α-synuclein-mediated demyelination in an in vitro model of multiple system atrophy. (2024/01/01) ♡
- Multivariate investigation of aging in mouse models expressing the Alzheimer's protective APOE2 allele: integrating cognitive metrics, brain imaging, and blood transcriptomics. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of lower urinary tract symptoms in Parkinsonian disorders. (2024/01/01) ♡
- Progression of Myopic Maculopathy Based on the ATN Classification System. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An overview on pure autonomic failure. (2024/01/01) ♡
- Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Effect of Levodopa on Heat Hypersensitivity and Complex Motor Parkinsonism. (2024/01/01) ♡
- Cranial Nerve Thinning Distinguishes RFC1-Related Disorder from Other Late-Onset Ataxias. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of ATH434 in Participants with Multiple System Atrophy (2024-12-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) (2024-12-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Monogenic Diabetes Misdiagnosed as Type 1 (2024-12-10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation (2024-12-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms) (2024-12-04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia (2024-12-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders (2024-11-21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Spinraza in Adult Spinal Muscular Atrophy (2024-11-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. North American Prodromal Synucleinopathy Consortium (2024-11-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy (2024-10-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes (2024-10-17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate QR-110 in Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene (2024-10-15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Effect of a Multi-intervention Program and Protein Food Sources on Preventing and Mitigating Sarcopenia (2024-10-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Ultrasound to Assess Sarcopenia in Prader Willi Syndrome (2024-10-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. (2024-09-24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations (2024-09-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA) (2024-09-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Neurodegenerative Diseases Progression Markers (MARKERS-NDD) (2024-09-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of Combined Exercise Training in Patients With Multiple Sclerosis (2024-09-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. I-Tracking Neurodegeneration in Early Wolfram Syndrome (2024-08-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy (2024-07-31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts (2024-07-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treatment of Transcranial Alternating Current Stimulation (tACS) on Cerebellar Ataxia (2024-07-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome (2024-07-08) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.